FGF21 and hypertensive disorder: These results suggest that a peak of FGF-21 towards the end of pregnancy in healthy pregnancy women and higher levels of FGF-21 throughout gestation in preeclamptic women compared with healthy normotensive pregnant women might play a critical role that contributes to protecting against the deleterious effects of high NEFA concentrations and hypertensive disorder.